Tag: Lilly Asia Ventures

Qiming Venture Partners Leads $42M New Round In Chinese Biotech Start-Up

Sophy Yang -

Chinese Clinical Stage Biotech Firm InventisBio Closes $70M Series C Round

Sophy Yang -

DealShot: 12 Deals Topping $102 Million Involving Temasek, Eight Roads, Lilly...

Katherine Guo -

Temasek Leads $85M Series B Round In Chinese Biotech Start-Up

Sophy Yang -

GIC Leads $125M Series C Round In Chinese Cancer Diagnostics Firm...

Sophy Yang -

Lilly Asia Ventures Receives $40M Commitment From US Pension Fund SFERS

Sophy Yang -

Green Pine Leads Series Pre-B Plus Round In Chinese Genome Editing...

Eudora Wang -

Hillhouse Capital Invests $35M Series A+ Round In Chinese Biopharmaceutical Firm...

Violet Tang -

Hillhouse, Quan Capital Lead $93M Series B Round In Biopharma Firm...

Eudora Wang -

Vivo Capital, OrbiMed Lead $80M Series B Round In Biopharmaceutical Start-Up...

Sophy Yang -

Temasek-Backed Biotech Firm Innovent Seeks To Raise Up To $500M In...

Eudora Wang -

Agilent Technologies Acquires Qiming-backed Biotechnology Firm ACEA Biosciences

Sophy Yang -

First Patient Dosed in a Phase III Trial of Anti-PD-1 Antibody...

PR Newswire -

DealShot: Lilly Asia Ventures Leads $14.5M Pre-B Round In Chinese Biotech...

Katherine Guo -

Decheng Capital Leads $30M Series C Round In China’s Impact...

Yimian Wu -

Hillhouse Capital Leads $35M Series B+ Round In Hangzhou Just Biotherapeutics

Yimian Wu -

Capital Group Private Markets Leads $150M Round In China’s Innovent Biologics

Yimian Wu -

Pfizer Takes Stake In Chinese Biotech Firm NetVation, Plans Research Collaboration

Yimian Wu -

China’s Ping An Ventures Leads $100M A Round In American Biotherapeutics...

Yimian Wu -

DealShot: Lilly Asia Ventures Co-Leads $76M New Round In Chinese Biotechnology...

Katherine Guo -

Top Chinese Healthcare Investors Excited For Market Opportunities In China

Katherine Guo -

China Money Network AI Evolution Event Series Tackles Impact Of Artificial...

Katherine Guo -

Lilly Asia Ventures Closes Fourth Fund At $450 Million Hard Cap

Pan Yue -

Temasek Leads $59M Round In Chinese Biotherapeutics Developer Just China

Pan Yue -

China Healthcare Investor Forum 2017

Katherine Guo -

Fosun Kinzon Changes Name To Fosun RZ Capital

Pan Yue -

OrbiMed Asia Leads $19M Series B Round In Biotech Start-Up InventisBio

Jillian Yue -

InventisBio Raises USD19 Million in Series B Financing Led by OrbiMed

Syndicated Press Releases -

Qiming Venture Leads Series B Round In China’s Microtech Medical

Katherine Guo -

Innovent Biologics, Inc. Raises USD $260M in Series D Financing

Syndicated Press Releases -

Sequoia-Backed Betta Pharma Completes $106M IPO In China’s ChiNext Board

Li Dongmei -

Want to see more data? Registered subscribers can see all the data.

   Register Now!
China Money Network Subscription
© 2019 China Money Network Limited. All Rights Reserved. Disclaimer: The views, opinions, forecasts, and statements made by our hosts and guests are the personal views of those respective individuals and may or may not be either endorsed or accepted by China Money Network Limited or the companies with which these individuals are employed.